296 related articles for article (PubMed ID: 17721813)
21. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a.
Jarosinski KW; Osterrieder N; Nair VK; Schat KA
J Virol; 2005 Sep; 79(18):11647-59. PubMed ID: 16140742
[TBL] [Abstract][Full Text] [Related]
22. The Tegument Protein pUL47 of Marek's Disease Virus Is Necessary for Horizontal Transmission and Is Important for Expression of Glycoprotein gC.
Chuard A; Courvoisier-Guyader K; Rémy S; Spatz S; Denesvre C; Pasdeloup D
J Virol; 2020 Dec; 95(2):. PubMed ID: 32999032
[TBL] [Abstract][Full Text] [Related]
23. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
24. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
Spatz SJ; Rue CA
Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
[TBL] [Abstract][Full Text] [Related]
27. Genotypic characterization of two bacterial artificial chromosome clones derived from a single DNA source of the very virulent gallid herpesvirus-2 strain C12/130.
Spatz SJ; Smith LP; Baigent SJ; Petherbridge L; Nair V
J Gen Virol; 2011 Jul; 92(Pt 7):1500-1507. PubMed ID: 21450941
[TBL] [Abstract][Full Text] [Related]
28. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease.
Baigent SJ; Petherbridge LJ; Smith LP; Zhao Y; Chesters PM; Nair VK
J Gen Virol; 2006 Apr; 87(Pt 4):769-776. PubMed ID: 16528024
[TBL] [Abstract][Full Text] [Related]
29. Vaccinal efficacy of molecularly cloned
Kim T; Spatz SJ; Dunn JR
J Gen Virol; 2020 May; 101(5):542-552. PubMed ID: 32134378
[TBL] [Abstract][Full Text] [Related]
30. The Marek's Disease Virus Unique Gene MDV082 Is Dispensable for Virus Replication but Contributes to a Rapid Disease Onset.
You Y; Conradie AM; Kheimar A; Bertzbach LD; Kaufer BB
J Virol; 2021 Jul; 95(15):e0013121. PubMed ID: 34011541
[TBL] [Abstract][Full Text] [Related]
31. Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis.
Niikura M; Kim T; Silva RF; Dodgson J; Cheng HH
J Gen Virol; 2011 Mar; 92(Pt 3):598-607. PubMed ID: 21123546
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus.
Singh SM; Baigent SJ; Petherbridge LJ; Smith LP; Nair VK
Res Vet Sci; 2010 Aug; 89(1):140-5. PubMed ID: 20144837
[TBL] [Abstract][Full Text] [Related]
33. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
Witter RL; Kreager KS
Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
[TBL] [Abstract][Full Text] [Related]
34. Interferon-containing supernatants increase Marek's disease herpesvirus genomes and gene transcription levels, but not virion replication in vitro.
Levy AM; Burgess SC; Davidson I; Underwood G; Leitner G; Heller ED
Viral Immunol; 2003; 16(4):501-9. PubMed ID: 14733737
[TBL] [Abstract][Full Text] [Related]
35. Marek's disease alphaherpesvirus (MDV) RLORF4 is not required for expression of glycoprotein C and interindividual spread.
Vega-Rodriguez W; Ponnuraj N; Jarosinski KW
Virology; 2019 Aug; 534():108-113. PubMed ID: 31226665
[TBL] [Abstract][Full Text] [Related]
36. Newly detected mutations in the Meq oncogene and molecular pathotyping of very virulent Marek's disease herpesvirus in Tunisia.
Lachheb J; Mastour H; Nsiri J; Kaboudi K; Choura I; Ammouna F; Amara A; Ghram A
Arch Virol; 2020 Nov; 165(11):2589-2597. PubMed ID: 32876794
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Marek's disease virus in different chicken populations in Iraq and indicative virulence based on sequence variation in the ecoRI-q (meq) gene.
Wajid SJ; Katz ME; Renz KG; Walkden-Brown SW
Avian Dis; 2013 Jun; 57(2 Suppl):562-8. PubMed ID: 23901776
[TBL] [Abstract][Full Text] [Related]
38. Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions.
Petherbridge L; Xu H; Zhao Y; Smith LP; Simpson J; Baigent S; Nair V
J Virol Methods; 2009 Jun; 158(1-2):11-7. PubMed ID: 19187788
[TBL] [Abstract][Full Text] [Related]
39. Latency and tumorigenesis in Marek's disease.
Nair V
Avian Dis; 2013 Jun; 57(2 Suppl):360-5. PubMed ID: 23901747
[TBL] [Abstract][Full Text] [Related]
40. The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus.
Anderson AS; Parcells MS; Morgan RW
J Virol; 1998 Mar; 72(3):2548-53. PubMed ID: 9499123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
